BridgeMD
New treatment option for Cholecystectomy
Official title Effect of Ketalar or Dexmedetomidine on Increased Sensitivity to Pain Following Treatment With Remifentanil
ClinicalTrials.gov ID: NCT06473896
What this study is testing
What is Ketalar?
Ketalar is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for cholecystectomy.
Also referred to as Ketamine.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Analgesia is one of the pillars of anesthesia. One of the common opiates for pain relief, with a short half-life, is Remifentanil.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Patients who are about to undergo alaparoscopic cholecystectomy under general anesthesia
You likely can't join if
- Patients with sensitivity to the anesthetic
- Patients with chronic pain who are in regular treatment
- Urgent surgery
- Patients with ischemic heart disease
- Patients with known bradycardia
- Patients with a pacemaker
See the full eligibility criteria
- Patients who are about to undergo alaparoscopic cholecystectomy under general anesthesia
- Patients with sensitivity to the anesthetic
- Patients with chronic pain who are in regular treatment
- Urgent surgery
- Patients with ischemic heart disease
- Patients with known bradycardia
- Patients with a pacemaker
- Prolonged use of opiates
- Kidney/liver function problems
The study team makes the final eligibility decision.
Where it's taking place
- Be’er Ya‘aqov, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Be’er Ya‘aqov, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.